Skip to main content
Clinical Trials/NCT01910493
NCT01910493
Completed
Not Applicable

Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique: A Randomized Control Trial

Absolute Return for Kids1 site in 1 country1,352 target enrollmentNovember 2011
ConditionsHIV-positive

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV-positive
Sponsor
Absolute Return for Kids
Enrollment
1352
Locations
1
Primary Endpoint
Retention in ART care
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Mobile phone SMS are increasingly used to promote positive health behaviour with an aim to improve health outcomes. However, robust data on the efficacy of SMS on health seeking behaviour and patient outcomes in resource-limited settings is sparse. The SMSaude study aims to assess whether regular SMS-reminders improve retention on antiretroviral therapy (ART) and prevention of mother to child transmission of HIV (PMTCT) programmes in Mozambique.

Detailed Description

SMSaúde is a multisite randomised clinical trial of HIV-infected adults on ART and HIV-infected pregnant women in six clinics in Maputo Province, Mozambique. Eligibility criteria include: currently residing in the province; no plans to move for 12+ months; have own cell-phone; literate; 8-28 weeks pregnant (PMTCT cohort); on first line ART and on ART for \>15 days (ART cohort). Patients were interviewed for eligibility, and then randomized (1:1). SMS reminders are sent to the intervention group using software that picks up the patient's next appointment from the electronic patient database. Primary outcomes tested were improved retention in ART care and uptake of all PMTCT services.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
June 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Absolute Return for Kids
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • On ART for \>15 days (for ART only)
  • Live in province and plan to stay for 12+ months
  • Have cell phone
  • For PMTCT (in addition to above criteria):
  • pregnant between 8-28 weeks

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retention in ART care

Time Frame: 12 months

Secondary Outcomes

  • Retention in PMTCT care(until 8 weeks post partum)

Study Sites (1)

Loading locations...

Similar Trials